10 YEARS OF LIVER-TRANSPLANTATION - AN EVOLVING UNDERSTANDING OF LATEGRAFT LOSS

Citation
O. Abbasoglu et al., 10 YEARS OF LIVER-TRANSPLANTATION - AN EVOLVING UNDERSTANDING OF LATEGRAFT LOSS, Transplantation, 64(12), 1997, pp. 1801-1807
Citations number
45
Journal title
ISSN journal
00411337
Volume
64
Issue
12
Year of publication
1997
Pages
1801 - 1807
Database
ISI
SICI code
0041-1337(1997)64:12<1801:1YOL-A>2.0.ZU;2-C
Abstract
Background. We undertook this study to understand the causes of late g raft loss and long-term outcome in orthotopic liver transplantation (O LT) recipients, Methods. Prospectively collected data of 1174 consecut ive OLT in 1045 adult patients who received liver grafts between April 1985 and August 1995 were reviewed. The causes of graft loss, pretran splant patient characteristics, and posttransplant events were analyze d in patients who survived at least 1 year after OLT, in an attempt to establish a link between these factors and graft loss, Results. One h undred fifty-nine (17.9%) grafts were lost after the first year. Of th ese, 132 grafts were lost by death and 27 by retransplantation. Recipi ents who survived the first year (n=884) had 5- and 10-year survivals of 81.4% and 67.2%, respectively, Death with a functioning graft occur red in 97 (61%) patients. The main causes of late graft loss were recu rrent disease (n=48), cardiovascular and cerebral vascular accidents ( n=28), infections (n=24), and chronic rejection (n=15). Pretransplant heart disease and diabetes were found to be significant risk factors f or late graft loss due to cardiovascular diseases and cerebral vascula r accidents, Conclusions. Survival of OLT patients who live beyond the first posttransplant year is excellent. Some patient characteristics may be associated with late graft loss, Compared with previous reports , this study shows an increased incidence of late graft loss secondary to recurrent diseases, de novo malignancies, cardiovascular diseases, and cerebral vascular accidents. Chronic rejection seems to be a less frequent cause of late graft loss, The prevention of recurrent diseas e and better immunosuppression may further improve these results.